These 3 Dividend Stocks Yield Less Than 10-year Treasurie…

First up is a name every American already knows.

CVS Health’s nationwide reach powers a bigger healthcare bet

Americans will be intimately familiar with CVS Health (CVS -0.57%). It’s the corner store that has just about everything: a pharmacist, a flu shot station, and even a phone charger if you’re in a pinch. The company has over 9,000 stores in the U.S., mostly in busy cities, strip malls, or other easily accessible locations.

This reach, this massive footprint, is a big part of the investment case. Its stores and large product portfolio provide a steady revenue stream that it uses to fund its much larger healthcare operations, including pharmacy services, insurance, and prescription delivery.

Expand

NYSE: CVS

CVS Health

Premium Feature

Moneyball Superscore

65/100

Today’s Change

(-0.57%) $-0.49

Current Price

$85.20

Key Data Points

Market Cap

$110BMarket cap calculated using publicly traded s outstanding only. Does not include unlisted, private, or dual-class non-traded s. Implied market cap may vary.

Day’s Range

$84.23 – $86.26

52wk Range

$69.51 – $110.68

Volume

6.6M

Avg Vol

7.7M

Gross Margin

14.16%

Dividend Yield

3.10%

And business has been good. CVS reported strong second-quarter results for 2026, beating analysts’ expectations on both adjusted earnings per (EPS) and revenue. The company also pays a $2.66-per-dividend, which translates to roughly a 3% yield.

Wall Street analysts the stock. A consensus among 24 analysts rates it a strong buy, with the high target price suggesting aproximately 45% upside over the next year.

But CVS isn’t the only healthcare name worth a look.

Abbott’s dividend history keeps growing despite recent setbacks

High Treasury yields can look attractive, but they’re often temporary. Meanwhile, a growing dividend from a reliable company is something investors can potentially build on for years.

Abbott Laboratories (ABT -2.17%) has built exactly that kind of track record. The company has paid over 400 quarterly dividends and increased its payouts for 54 consecutive years. Right now, the company pays $2.52 per , which translates to a yield of about 2.5%, well below the yield on 10-year Treasury bills these days. But over the last five years, Abbott has increased its dividend by 64%.

The underlying business is also still growing. Abbott beat its Q2 estimates and raised full-year EPS guidance, and management also expects growth to pick up in the second half.

Expand

NYSE: ABT

Abbott Laboratories

Premium Feature

Moneyball Superscore

73/100

Today’s Change

(-2.17%) $-2.14

Current Price

$96.69

Key Data Points

Market Cap

$171BMarket cap calculated using publicly traded s outstanding only. Does not include unlisted, private, or dual-class non-traded s. Implied market cap may vary.

Day’s Range

$96.54 – $99.44

52wk Range

$81.97 – $135.37

Volume

8.9M

Avg Vol

9.7M

Gross Margin

52.81%

Dividend Yield

2.51%

Analysts also the stock, assigning a consensus strong buy rating with up to 43% upside potential, citing its high target price.

There’s a third healthcare giant worth considering, too.

UnitedHealth’s size gives income investors more upside potential

UnitedHealth (UNH -0.51%) is the largest health insurer in the country, covering tens of millions of Americans through employer, Medicare, and Medicaid plans under its UnitedHealthcare arm. Its Optum division runs one of the biggest pharmacy benefit managers (OptumRx), employs or is affiliated with a large network of doctors, and sells data and technology services to the rest of the healthcare system.

Expand

NYSE: UNH

UnitedHealth Group

Premium Feature

Moneyball Superscore

71/100

Today’s Change

(-0.51%) $-1.88

Current Price

$365.20

Key Data Points

Market Cap

$329BMarket cap calculated using publicly traded s outstanding only. Does not include unlisted, private, or dual-class non-traded s. Implied market cap may vary.

Day’s Range

$362.60 – $371.86

52wk Range

$255.97 – $461.62

Volume

3.9M

Avg Vol

4.9M

Dividend Yield

2.47%

UnitedHealth has increased its dividends for the last 17 consecutive years. So even though the stock’s been relatively flat, up about 3% over the last five years, investors still got something out of the deal.

But how much, exactly? Well, the company pays a $9.28 forward dividend, which translates to about a 2.4% yield. Meanwhile, a consensus among 26 analysts maintains a strong buy rating for the stock, with a high target price implying 42% potential upside.

So which of these three is the best buy?

Which of these three dividend plays fits investors best?

Treasuries offer certainty, but their payout never grows. CVS, Abbott, and UnitedHealth all yield less than a 10-year note today, yet each brings what a Treasury can’t: a growing dividend and real upside if s move toward Wall Street’s highest targets.

Of the three, UnitedHealth is a proven cash generator whose stock appears fairly valued, with dividend growth and analyst targets suggesting patient investors could still be rewarded. Granted, none of them pays what the Treasury pays today, but if their dividends keep climbing and s close the gap to those price targets, the total return could beat a 5% note several times over.

Read Next

Sep 30, 2026 •By Matt DiLallo

SCHD’s Top Sector Bet Is Healthcare at 20.7%. I’m Not Sure What’s More Surprising: What It Doesn’t Hold, or What It Does.

Sep 24, 2026 •By Parkev Tatevosian, CFA

Is UnitedHealth Stock an Undervalued Stock to Buy Right Now?

Sep 21, 2026 •By David Jagielski, CPA

Should You Buy UnitedHealth Group Stock Before Oct. 13?

Sep 14, 2026 •By Keith Speights

6 Best Health Insurance Stocks for 2026 and How to Invest

Sep 8, 2026 •By Thomas Niel

UnitedHealth Group Stock Is Up 39.4% in the Last 6 Months. How High Can It Go?

Sep 7, 2026 •By Lyle Daly

The Largest Healthcare Companies by Market Cap in September 2026

About the Author

Rick is a Wall Street Journal best-selling author with over 20 years of experience trading stocks and options. The most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News, cover his work. His passion is business, and he works tirelessly to deliver content in an easy-to-understand manner. In 2018, Rick wrote The Financially Independent Millennial to inspire his readers with his story about becoming financially independent at age 35 despite not learning about money when he was younger. His books are easy to read and often refer to key points that “He would tell his younger self.” When not thinking about business, Rick writes (mainly about cruise ship travel) for his travel blog and is an enthusiast of fast cars, technology, & cooking.

CMFrickorford

Stocks Mentioned

Motley Fool Stock Advisor’s Latest Pick

Get Access

—% Avg Return

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.